Evidence map›Paper›PMID 26972579›Full record

ArticleScientific reports2016

Characterization and comparison of post-natal rat Achilles tendon-derived stem cells at different development stages.

Jialin Chen, Wei Zhang, Zeyu Liu, Ting Zhu, Weiliang Shen, Jisheng Ran, Qiaomei Tang, Xiaonan Gong, Ludvig J Backman, Xiao Chen and 3 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Three-Dimensional Cell Culture System for Tendon Tissue Engineering.Tissue engineering and regenerative medicine · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. SM04755, a small-molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jialin ChenCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Wei ZhangCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Zeyu LiuCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Ting ZhuCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Weiliang ShenCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Jisheng RanDepartment of Orthopaedics, Second Affiliated Hospital, Zhejiang University, Hangzhou, 310009, China.
Qiaomei TangCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Xiaonan GongCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Ludvig J BackmanDepartment of Integrative Medical Biology, Anatomy, Umeå University, Umeå, 90187, Sweden.
Xiao ChenCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Xiaowen ChenDivision of haematology and oncology, Shenzhen Children's Hospital, Shenzhen, 518038, China.
Feiqiu WenDivision of haematology and oncology, Shenzhen Children's Hospital, Shenzhen, 518038, China.
Hongwei OuyangCentre for Stem Cell and Tissue Engineering, School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Zhejiang University · CNSecond Affiliated Hospital of Zhejiang University · CNShenzhen Children's Hospital · CNUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tendon stem/progenitor cells (TSPCs) are a potential cell source for tendon tissue engineering. The striking morphological and structural changes of tendon tissue during development indicate the complexity of TSPCs at different stages. This study aims to characterize and compare post-natal rat Achilles tendon tissue and TSPCs at different stages of development. The tendon tissue showed distinct differences during development: the tissue structure became denser and more regular, the nuclei became spindle-shaped and the cell number decreased with time. TSPCs derived from 7 day Achilles tendon tissue showed the highest self-renewal ability, cell proliferation, and differentiation potential towards mesenchymal lineage, compared to TSPCs derived from 1 day and 56 day tissue. Microarray data showed up-regulation of several groups of genes in TSPCs derived from 7 day Achilles tendon tissue, which may account for the unique cell characteristics during this specific stage of development. Our results indicate that TSPCs derived from 7 day Achilles tendon tissue is a superior cell source as compared to TSPCs derived from 1 day and 56 day tissue, demonstrating the importance of choosing a suitable stem cell source for effective tendon tissue engineering and regeneration.

Indexed as

Achilles TendonAnimalsAnimals, NewbornCell DifferentiationCell ProliferationCells, CulturedCell Self RenewalGene Expression ProfilingGene Expression Regulation, DevelopmentalGene OntologyMicroscopy, Electron, TransmissionOligonucleotide Array Sequence AnalysisRatsReverse Transcriptase Polymerase Chain ReactionStem CellsTime Factors

Identifiers

PMID26972579
PMCPMC4789738
OpenAlexW2294259702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.